JP2009521905A - 冠動脈心疾患に関連する遺伝的多型、その検出方法および使用 - Google Patents

冠動脈心疾患に関連する遺伝的多型、その検出方法および使用 Download PDF

Info

Publication number
JP2009521905A
JP2009521905A JP2007502097A JP2007502097A JP2009521905A JP 2009521905 A JP2009521905 A JP 2009521905A JP 2007502097 A JP2007502097 A JP 2007502097A JP 2007502097 A JP2007502097 A JP 2007502097A JP 2009521905 A JP2009521905 A JP 2009521905A
Authority
JP
Japan
Prior art keywords
snp
nucleic acid
snps
protein
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007502097A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009521905A5 (enExample
Inventor
ドブ シッフマン，
ミシェル カーギル，
ジェームス デブリン，
Original Assignee
アプレラ コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アプレラ コーポレイション filed Critical アプレラ コーポレイション
Publication of JP2009521905A publication Critical patent/JP2009521905A/ja
Publication of JP2009521905A5 publication Critical patent/JP2009521905A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2007502097A 2004-03-05 2005-03-07 冠動脈心疾患に関連する遺伝的多型、その検出方法および使用 Pending JP2009521905A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US55005104P 2004-03-05 2004-03-05
US56783104P 2004-05-05 2004-05-05
US61716304P 2004-10-12 2004-10-12
PCT/US2005/007453 WO2005087953A2 (en) 2004-03-05 2005-03-07 Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof

Publications (2)

Publication Number Publication Date
JP2009521905A true JP2009521905A (ja) 2009-06-11
JP2009521905A5 JP2009521905A5 (enExample) 2009-07-23

Family

ID=34976300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007502097A Pending JP2009521905A (ja) 2004-03-05 2005-03-07 冠動脈心疾患に関連する遺伝的多型、その検出方法および使用

Country Status (5)

Country Link
US (2) US20060228715A1 (enExample)
EP (1) EP1745147A2 (enExample)
JP (1) JP2009521905A (enExample)
CA (1) CA2558458A1 (enExample)
WO (1) WO2005087953A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006103684A2 (en) * 2005-04-01 2006-10-05 Given Imaging Ltd. Device, system and method for in vivo magnetic immunoassay analysis
WO2007028147A2 (en) * 2005-09-01 2007-03-08 Philadelphia Health & Education Corporation D.B.A. Drexel University College Of Medicin Identification of a prostatic intraepithelial neoplasia (pin)-specific gene and protein (pin-1) useful as a diagnostic treatment for prostate cancer
US7799530B2 (en) 2005-09-23 2010-09-21 Celera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
CN101310026A (zh) * 2005-11-15 2008-11-19 弗·哈夫曼-拉罗切有限公司 AZGP基因单核苷酸多态性(SNPs)
EP2016197A4 (en) * 2006-04-21 2009-09-16 Celera GENETIC POLYMORPHISMS ASSOCIATED WITH CORONARY DISEASE, DETECTION METHODS AND JOBS
KR101571523B1 (ko) * 2007-02-21 2015-11-24 디코드 제네틱스 이에이치에프 심혈관 질환과 연관된 유전적 감수성 변이
WO2010006215A1 (en) * 2008-07-09 2010-01-14 Celera Corporation Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
ES2638779T3 (es) 2009-03-16 2017-10-24 Pangu Biopharma Limited Composiciones y procedimientos que comprenden variantes de splicing de histidil-tarn sintetasa que tienen actividades biológicas no canónicas
EP2496243A2 (en) * 2009-11-04 2012-09-12 Erasmus University Medical Center Rotterdam Novel compounds for modulating neovascularisation and methods of treatment using these compounds
CN106474462A (zh) 2009-12-11 2017-03-08 Atyr 医药公司 用于调节炎症的氨酰tRNA合成酶
US20130202576A1 (en) 2010-07-12 2013-08-08 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
HUE029534T2 (hu) * 2011-08-05 2017-02-28 Gendiag Exe Sl Genetikai markerek kardiovaszkuláris betegség kockázatának becslésére
US12077823B2 (en) 2011-08-05 2024-09-03 Genincode Plc Risk assessment for cardiovascular disease
CN104334196B (zh) 2012-02-16 2018-04-10 Atyr 医药公司 用于治疗自身免疫疾病和炎性疾病的组氨酰‑tRNA合成酶
AU2014233436B2 (en) 2013-03-15 2019-12-05 Atyr Pharma, Inc. Histidyl-tRNA synthetase-Fc conjugates
CN109906275B (zh) * 2016-06-08 2023-05-12 爱荷华大学研究基金会 检测心血管疾病易感性的组合物和方法
JP7679175B2 (ja) 2017-04-20 2025-05-19 エータイアー ファーマ， インコーポレイテッド 肺の炎症を治療するための組成物および方法
EP3935581A4 (en) 2019-03-04 2022-11-30 Iocurrents, Inc. DATA COMPRESSION AND COMMUNICATION USING MACHINE LEARNING
CN113637738B (zh) * 2021-08-08 2023-07-28 华中科技大学同济医学院附属协和医院 与冠心病相关的snp位点及其应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002136291A (ja) * 2000-11-02 2002-05-14 Univ Nihon 心筋梗塞の遺伝的要因を判定するための方法及びこれに使用されるオリゴヌクレオチド
WO2003072813A2 (en) * 2002-02-27 2003-09-04 Bayer Healthcare Ag Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy
JP2004024036A (ja) * 2002-06-21 2004-01-29 Nagoya Industrial Science Research Inst 心筋梗塞のリスク診断方法
WO2004015100A1 (ja) * 2002-08-08 2004-02-19 Riken 炎症性疾患の判定方法
JP2004065203A (ja) * 2002-08-09 2004-03-04 Nagoya Industrial Science Research Inst 冠動脈形成術後再狭窄のリスク診断方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
US20030092019A1 (en) * 2001-01-09 2003-05-15 Millennium Pharmaceuticals, Inc. Methods and compositions for diagnosing and treating neuropsychiatric disorders such as schizophrenia

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002136291A (ja) * 2000-11-02 2002-05-14 Univ Nihon 心筋梗塞の遺伝的要因を判定するための方法及びこれに使用されるオリゴヌクレオチド
WO2003072813A2 (en) * 2002-02-27 2003-09-04 Bayer Healthcare Ag Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy
JP2004024036A (ja) * 2002-06-21 2004-01-29 Nagoya Industrial Science Research Inst 心筋梗塞のリスク診断方法
WO2004015100A1 (ja) * 2002-08-08 2004-02-19 Riken 炎症性疾患の判定方法
JP2004065203A (ja) * 2002-08-09 2004-03-04 Nagoya Industrial Science Research Inst 冠動脈形成術後再狭窄のリスク診断方法

Also Published As

Publication number Publication date
CA2558458A1 (en) 2005-09-22
EP1745147A2 (en) 2007-01-24
US20090264453A1 (en) 2009-10-22
US20060228715A1 (en) 2006-10-12
WO2005087953A8 (en) 2005-12-15
WO2005087953A2 (en) 2005-09-22
WO2005087953A3 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
JP7175371B2 (ja) スタチンの応答および心血管疾患に関連する遺伝子多型、その検出方法ならびに使用
JP5111380B2 (ja) 心臓血管障害および薬物応答に関連する遺伝的多型、その検出方法および使用
JP6316994B2 (ja) 心筋梗塞に関連する遺伝的多型、その検出方法および使用
JP6124968B2 (ja) 肝線維症に関連する遺伝的多型、その検出方法および使用
US20090170111A1 (en) Genetic polymorphisms associated with stroke, methods of detection and uses thereof
US20090264453A1 (en) Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
JP2009519001A (ja) 狭窄に関連する遺伝的多型、その検出方法および使用
US20070042382A1 (en) Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
JP5268145B2 (ja) アルツハイマー病に関連する遺伝的多型、その検出方法および使用
JP2013138686A (ja) 冠動脈事象および薬物応答に関連する遺伝的多型、その検出方法および使用
JP2013078314A (ja) 冠動脈心疾患に関連する遺伝的多型、その検出方法および使用
US20050287559A1 (en) Genetic polymorphisms associated with vascular, methods of detection and uses thereof

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101105

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110331